glp-1/fgf21 agonist boehringer Safety and efficacy of dual HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study Boehringer Ingelheim, Yuhan Launch Up-to-$870M+
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21


















![Wegovy Vision Loss Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/07/wegovy-blurred-vision.webp)






